UNSPSC 51372803: Nefopam

This classification denotes a benzodiazepine with the molecular formula C17H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4UP8060B7J, chemically known as 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1h-2,5-benzoxazocin but generally known as nefopam, which bears US NIH Compound Identifier 4450. European Medicines Agency schedules Nefopam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09183MIG.

UNSPSC 51372803 Nefopam is a Commodity code capturing pharmaceutical products for emergency medical response and public health interventions. State and local governments procure naloxone and related drug-response products under this code to support community health and opioid-crisis initiatives. The solicitations reflect purchases by county health departments and public safety agencies seeking to stock emergency supplies for distribution to community health facilities, first responders, or public-health programs. These procurements typically involve fixed-price supply contracts with multi-year terms and renewal options, requiring vendors to meet standard compliance certifications including drug-free workplace status, E-Verify authorization, and specified insurance coverage.

Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford. The bid deadline was July 26, 2023, with a two-year initial term and one-year renewal option awarded on a fixed-fee basis. The procurement noted potential FEMA funding and subject vendors to federal environmental compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Beyond this single recent opportunity, the source provides no additional state or local solicitations under the code, limiting visibility into geographic spread or repeat-buyer patterns.